- Home
- ONC vs STLA Comparison
ONC vs STLA Comparison
Compare ONC & STLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ONC | STLA |
|---|---|---|
| Founded | 2010 | 2021 |
| Country | Switzerland | Netherlands |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Auto Manufacturing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 34.8B | 32.7B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | ONC | STLA |
|---|---|---|
| Price | $337.95 | $9.62 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 12 | 5 |
| Target Price | ★ $369.50 | $12.49 |
| AVG Volume (30 Days) | 290.3K | ★ 11.5M |
| Earning Date | 02-26-2026 | 02-25-2026 |
| Dividend Yield | N/A | ★ 6.02% |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.58 | N/A |
| Revenue | $4,972,687,000.00 | ★ $171,605,402,237.00 |
| Revenue This Year | $895.40 | $0.20 |
| Revenue Next Year | $22.04 | $5.45 |
| P/E Ratio | $545.93 | ★ N/A |
| Revenue Growth | ★ 50.43 | N/A |
| 52 Week Low | $196.45 | $8.39 |
| 52 Week High | $385.22 | $14.28 |
Technical Indicators
Market Signals| Indicator | ONC | STLA |
|---|---|---|
| Relative Strength Index (RSI) | 56.53 | 30.13 |
| Support Level | $332.53 | $10.07 |
| Resistance Level | $353.10 | $11.32 |
| Average True Range (ATR) | 10.13 | 0.23 |
| MACD | 3.44 | -0.17 |
| Stochastic Oscillator | 71.03 | 1.34 |
Price Performance
Historical ComparisonAbout ONC BeiGene Ltd. American Depositary Shares
Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeOne is a commercial-stage biotechnology company with global sales. It focuses on oncology therapeutics and differentiates itself from other companies with a contract research organization-free, or CRO-free strategy. BeOne runs global clinical trials with its own team. As of 2024, its core drug is Brukinsa, a small molecule drug for various blood cancers that makes up more than 60% of BeOne's revenue.
About STLA Stellantis N.V.
Stellantis was created out of the merger of US-based Fiat Chrysler Automobiles and French-based Peugeot in January 2021, resulting in the fourth-largest automotive original equipment manufacturer by vehicle sales. In 2024 it sold 5.5 million vehicles, 47%, 26% and 17% in Europe, North America, and South America, respectively. Its brands include Fiat, Jeep, Chrysler, Ram, Peugeot, Citroën, Opel, Alfa Romeo, and Maserati.